当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2018年第16期
编号:13297871
骨性关节炎中lncRNA MEG3的表达及其与VEGF的相关性分析(5)
http://www.100md.com 2018年6月5日 《中国医药导报》 2018年第16期
     [15] Mapp PI,Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis [J]. Nat Rev Rheumatol,2012,8(7):390-398.

    [16] Gerber HP,Vu TH,Ryan AM,et al. VEGF couples hypertrophic cartilage remodeling,ossification and angiogenesis during endochondral bone formation [J]. Nat Med,1999,5(6):623-628.

    [17] Harper J,Klagsbrun M. Cartilage to bone--angiogenesis leads the way [J]. Nat Med,1999,5(6):617-618.

    [18] Zhou Y,Zhong Y,Wang Y,et al. Activation of p53 by MEG3 non-coding RNA [J]. J Biol Chem,2007,282(34):24 731-24 742.

    [19] Zhou Y,Zhang X,Klibanski A. MEG3 noncoding RNA:a tumor suppressor [J]. J Mol Endocrinol,2012,48(3):R45-R53.

    [20] Pal S,Datta K,Mukhopadhyay D. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor(VPF/VEGF)expression in mammary carcinoma [J]. Cancer Res,2001,61(18):6952-6957.

    [21] Zhu J,Liu S,Ye F,et al. Long noncoding RNA MEG3 interacts with p53 protein and regulates partial p53 target genes in hepatoma cells [J]. PLoS One,2015,10(10):e0139790., http://www.100md.com(刘振峰 梁治权 邓迎杰 方锐 孟庆才)
上一页1 2 3 4 5